Evidence map›Paper›PMID 36635654›Full record

Observational studyBMC ophthalmology2023

Ocular and visual perceptive factors associated with treatment outcomes in patients with anisometropic amblyopia.

Jie Hong, Debbie Kuo, Han Su, Lei Li, Yanan Guo, Hang Chu, Jing Fu

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC ophthalmology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Multi-Feature Mapping of Distortions in Amblyopia With Localized Sampling.Investigative ophthalmology & visual science · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Add-on perceptual learning on refractive amblyopia in children.International journal of ophthalmology · 2024
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Jie HongBeijing Ophthalmology & Visual Sciences Key Lab, Dongcheng District, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, 1 Dongjiaominxiang Street, Beijing, China.
Debbie KuoPalo Alto Medical Foundation, Palo Alto, CA, USA.
Han SuBeijing Ophthalmology & Visual Sciences Key Lab, Dongcheng District, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, 1 Dongjiaominxiang Street, Beijing, China.
Lei LiBeijing Ophthalmology & Visual Sciences Key Lab, Dongcheng District, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, 1 Dongjiaominxiang Street, Beijing, China.
Yanan GuoBeijing Ophthalmology & Visual Sciences Key Lab, Dongcheng District, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, 1 Dongjiaominxiang Street, Beijing, China.
Hang ChuGuangdong Medical Device Research Institute, Guangzhou, China.
Jing FuBeijing Ophthalmology & Visual Sciences Key Lab, Dongcheng District, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, 1 Dongjiaominxiang Street, Beijing, China. fu_jing@126.com.
Capital Medical University · CNBeijing Tongren Hospital · CNPalo Alto Institute · US

Funding

Beijing Municipal Administration of Hospitals Incubating Program PX2018008High Level Health Technical Talent Training Program of the Beijing Municipal Commission for Health and Family Planning under Grant 2015-3-023Program for Excellent Talents supported Beijing Municipality 2015000021469G225Technology Achievements and Appropriate Technology Promotion Projects of Beijing Municipal, Commission for Health and Family Planning Health 2015-TG-15The Priming Scientific Research Foundation for the senior researcher in Beijing Tongren Hospital, Capital Medical University 2017-YJJ-GGL-002
6 · The paper itself

Abstract

backgroundThe aim of this observational study was to identify ocular and visual perceptive risk factors related to treatment results following refractive correction and patching in children with anisometropic amblyopia, who were between the ages of 4 to 14 years old.

methodsOne-hundred and two children with newly diagnosed anisometropic amblyopia were recruited. Successful treatment of amblyopia was defined as the final best corrected visual acuity (BCVA) better than or equal to 0.1 logMAR and amblyopic eye BCVA within 1 line of the sound eye BCVA by the end of the treatment period. BCVA, cycloplegic refraction, stereoacuity, perceptual eye position (PEP) and interocular suppression were measured.

resultsOf these patients, 45.10% achieved successful treatment of amblyopia after refractive correction and patching for 10.5 months. The mean age was not significantly different between patients who were successfully and unsuccessfully treated (5.50 ± 1.59 years vs 6.14 ± 2.19 years, respectively). Patients who failed treatment had significantly larger interocular difference of BCVA at the time of initial treatment (successful group: 0.33 ± 0.29 logMAR, unsuccessful group: 0.65 ± 0.35 logMAR) and after refractive adaptation (successful group: 0.15 ± 0.13 logMAR, unsuccessful group: 0.42 ± 0.35 logMAR). They also had higher spherical equivalent (SE) of amblyopic eyes (successful group: 3.08 ± 3.61 D, unsuccessful group: 5.27 ± 3.38 D), bigger interocular difference of SE (successful group: 0.94 ± 2.71 D, unsuccessful group: 3.09 ± 3.05 D), worse stereoacuity (successful group: 2.32 ± 0.37 log seconds of arc, unsuccessful group: 2.75 ± 0.32 log seconds of arc), larger vertical PEP deviation (successful group: 6.41 ± 6.08 pixel, unsuccessful group: 19.07 ± 24.96 pixel) and deeper interocular suppression (successful group: 21.7 ± 19.7%, unsuccessful group: 37.8 ± 27.1%) than those of successfully treated patients. The most influential treatment failure risk factors were larger vertical PEP deviation [adjusted odds ratio (OR) (95% confidence interval) 1.12 (1.02-1.22)] and worse stereoacuity [adjusted odds ratio (OR) (95% confidence interval) 7.72 (1.50-39.85)] in multiple logistic regression analysis.

conclusionsLarger vertical PEP deviation and worse stereoacuity were the most influential treatment failure risk factors in children with anisometropic amblyopia. The vertical PEP deviation and stereoacuity, which can reflect interocular interaction, may be useful in predicting the response to therapy.

Indexed as

AmblyopiaAdolescentChildChild, PreschoolHumansRefraction, OcularTreatment FailureTreatment OutcomeVisual AcuityAnisometropic amblyopiaPerceptual eye position (PEP)Risk factorsStereoacuitySuppression

Identifiers

PMID36635654
PMCPMC9837961
OpenAlexW4315785233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.